Cannovex

Cannovex develops a proprietary dry powder inhalation platform for cannabinoid medicines targeting oncology supportive care and acute pain.

Overview

Cannovex is developing a proprietary dry powder inhalation (DPI) platform for oncology supportive care and acute pain applications.

Something wrong or missing? Send an update. Fixed within 24 hours.